Editorial: Nonsurgical palliation of congenital heart malformations.
D000818:Animals; D001011:Aorta / Q000002:abnormalities; D003490:Cyanosis / Q000517:prevention & control; D004373:Ductus Arteriosus / Q000187:drug effects; D005557:Formaldehyde / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D006330:Heart Defects, Congenital / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D000860:Hypoxia / Q000517:prevention & control; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D007267:Injections; D007275:Injections, Intravenous; D010100:Oxygen / Q000097:blood; D010166:Palliative Care; D011458:Prostaglandins E / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000002:abnormalities; D011652:Pulmonary Circulation; D012756:Sheep
D011458:Prostaglandins E; D005557:Formaldehyde; D010100:Oxygen